Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Adjuvant 3D-Conformal Radiotherapy in High Risk Bladder Cancer

NCT01954173 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01954173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01954173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Adjuvant 3D-Conformal Radiotherapy in High Risk Bladder Cancer
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Terminated
Start date
July 22, 2013
Completion date
September 20, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, squamous cell carcinoma of the bladder, stage iii bladder cancer, stage iv bladder cancer, transitional cell carcinoma of the bladder